Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rhone-Poulenc Rorer

Executive Summary

Management of newly acquired Rorer will include: Chairman, CEO and President Robert Cawthorn; Randy Thurman, exec VP and group president of the businesses in the U.S., Canada, Japan, Korea, Australia, New Zealand, Mexico, Puerto Rico, Central America, Armour Pharmaceuticals, worldwide manufacturing and materials management; Jean-Jacques Bertrand, exec VP and group president of operations in Europe, Africa, South America, Near and Middle East and the Far East outside Japan and Korea; James Tretter, PhD, senior VP and president, Rhone-Poulenc Rorer Central Research; Patrick Langlois, senior VP and chief financial officer; John Bartlett, senior VP, general counsel and secretary; Gilles Brisson, senior VP-corporate development; Steven Baumgartner, senior VP-human resources and public affairs; and James Yahres, director of investor relations.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS017863

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel